Facebook
Twitter
LinkedIn
Forward
Hepatitis C in Advanced Chronic Kidney Disease: Addressing the High-Risk Patient - A Two-Part Series
This multi-activity series will address the clinical challenge of evaluating and treating Hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD). Content will describe the pathogenesis of HCV infection and its associations with CKD. Diagnostic modalities for HCV infection will also be discussed. The benefits and limitations of conventional antiviral regimens will be addressed. Recent clinical evidence for direct acting antivirals (DAAs) will also be included.
Supported by an educational grant from AbbVie.
Target Audience
- Physicians
- Pharmacists
- Physician Assistants
- Nurse Practitioners
- Nurses
- Dietitians
- Social Workers
To access an activity in this series:
- Create an account/login
- Review the information on the "Overview" and "Accreditation" tabs before clicking "Register"
- Click on the title of the module you wish to take
- Review information for this specific module before proceeding by clicking "Continue"
Acknowledgements:
Supported by an educational grant from AbbVie Inc.
Please see each individual activity for their accrediation and method of participation information.
Available Credit
Accreditation Period
Course opens:
01/15/2018
Course expires:
06/20/2019